Chris Kamara opens up on 'challenging' health issue - 'I thought I was invincible'
CHRIS KAMARA has opened up about his seven-month battle with hypothyroidism on Twitter, in support of Mental Health Day. The father-of-two spoke about his mental health struggles, which he "suffered" in silence. (Source: Daily Express - Health)
Source: Daily Express - Health - October 10, 2021 Category: Consumer Health News Source Type: news

A case of myxedema coma crisis induced by inhalation injury - Jawed M, Osella J, Bani Hani D.
Myxedema coma is a life-threatening, critical  condition in which many organ systems can be severely affected. It is considered the most severe presentation of hypothyroidism and should be treated immediately. Here, we discuss the case of a 58-year-old pat... (Source: SafetyLit)
Source: SafetyLit - September 20, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news

Janssen Demonstrates Commitment to Advancing Science and Innovation in the Treatment of Solid Tumors at ESMO Annual Congress
September 8, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than ten data presentations from its lung cancer, bladder cancer and prostate cancer portfolio and pipeline will be featured during the European Society for Medical Oncology (ESMO) Annual Congress 2021 virtual meeting, September 16–21. Further details about these data and the science Janssen is advancing will be made available throughout ESMO via the Janssen Oncology Virtual Newsroom.“With a diverse oncology portfolio and pipeline spanning bladder cancer, lung cancer and prostate can...
Source: Johnson and Johnson - September 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to Advancing Science for Genitourinary Cancers at AUA 2021
August 31, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple company-sponsored presentations in prostate and bladder cancers will be highlighted at the virtual 2021 American Urological Association Annual Meeting (AUA 2021), September 10-13. “Janssen maintains a strong commitment to advancing innovation and new therapeutic options for patients with genitourinary malignancies. As the treatment of genitourinary cancers becomes more complex, we continue to work with urologists and their teams to improve outcomes for patients across the continuum of disease...
Source: Johnson and Johnson - August 31, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Hypothyroidism: The common complaint that may be an early warning sign
HYPOTHYROIDISM is found in about two percent of the UK population, with women five to ten times more likely to be affected than men. The condition features chronic energy loss, weight gain, depression and hair loss, putting strain on day-to-day life. Over the last couple of decades, the condition has been linked to a specific type of pain. Pharmacist Carolina Goncalves explains how the two are linked. (Source: Daily Express - Health)
Source: Daily Express - Health - August 29, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic Q & amp;A podcast: Overtreating an underactive thyroid
The thyroid gland creates and produces hormones that play a role in many systems throughout the body. When your thyroid makes too much or too little of these important hormones, it ’s called thyroid disease. And thyroid disease is common. "We know that about 10% of people have some degree of thyroid dysfunction," says Dr. Juan Brito Campana, a Mayo Clinic endocrinologist. There are several different types of thyroid disease, including hyperthyroidism, or overactive thyroid; hypothyroidism… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 6, 2021 Category: Databases & Libraries Source Type: news

Diet for hypothyroidism: Healthy foods that may negatively affect thyroid function
HYPOTHYRODISM - otherwise known as an underactive thyroid - occurs when the thyroid gland doesn't produce enough of the hormone thyroxine . Common symptoms include tiredness, weight gain, and feeling depressed. (Source: Daily Express - Health)
Source: Daily Express - Health - July 16, 2021 Category: Consumer Health News Source Type: news

Diagnosis, Management of Hypothyroidism is Assay-Dependent Diagnosis, Management of Hypothyroidism is Assay-Dependent
The differences and variations between thyroid assays could have important implications for the diagnosis and management of subclinical hypothyroidism.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 9, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Overuse of levothyroxine in the United States
One of the most common prescription drugs in America – levothyroxine – is used by people with underactive thyroid glands, also known as hypothyroidism. However, a new study by Mayo Clinic researchers says the majority of people were initiated on levothyroxine for mild subclinical hypothyroidism or for no apparent thyroid dysfunction. These results , published in JAMA Internal Medicine, suggest significant overuse of levothyroxine. Mayo researchers and colleagues examined retrospective, deidentified case data using the OptumLabs Data… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 28, 2021 Category: Databases & Libraries Source Type: news

Levothyroxine Overprescribing Is Common, Consistent Over Time Levothyroxine Overprescribing Is Common, Consistent Over Time
A study detailing the consistent overuse of the thyroid replacement drug over a decade should be a'call to action'for doctors to stop treating patients with mild subclinical hypothyroidism, experts say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 24, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

What Foods Should Be Avoided with Hypothyroidism
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 24, 2021 Category: General Medicine Source Type: news

Older Therapies Aren ’t Necessarily Better for Thyroid Hormone Replacement
Millions of people have thyroid glands that don ’t make enough thyroid hormone to meet their body’s needs. Hypothyroidism (underactive thyroid) is the most common reason some people need thyroid hormone replacement. Today, there are modern, synthetic (laboratory-made) medications approved by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 14, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

What's Behind Brain Fog in Treated Hypothyroidism?
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 9, 2021 Category: General Medicine Source Type: news

What's Behind Brain Fog in Treated Hypothyroidism? What's Behind Brain Fog in Treated Hypothyroidism?
Large survey believed to be the first to explore the common phenomenon and identify potential avenues of treatment.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 8, 2021 Category: Neurology Tags: Diabetes & Endocrinology News Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Long-Term ERLEADA ® (apalutamide) Patient-Reported Outcomes Data in Metastatic Castration-Sensitive Prostate Cancer Demonstrate Maintenance of Health-Related Quality of Life for Patients
May 26, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced patient-reported outcomes (PRO) data from the pre-specified final analysis of the Phase 3 TITAN study in patients with metastatic castration-sensitive prostate cancer (mCSPC). The TITAN study previously demonstrated statistically significant improvement in overall survival (OS) after a median follow-up of 44 months in patients receiving ERLEADA® plus androgen deprivation therapy (ADT).1 The new PRO data showed that the addition of ERLEADA® to ADT maintained patients’ health-related quality of lif...
Source: Johnson and Johnson - May 26, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Some NP Thyroid Lots Recalled Due to Reduced Potency Some NP Thyroid Lots Recalled Due to Reduced Potency
For the third time in a year, Acella Pharma announced a US recall of specific lots of its popular hypothyroid treatment NP Thyroid tablets USP, this time after testing found the pills to be subpotent.News Alerts (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 4, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

What Are Some Etiologies for Intellectual Disability?
Discussion “Intellectual disability (ID) is a neurodevelopmental disorder that is characterized by deficits in both intellectual functioning and adaptive function whose onset is in the development period.” Global developmental delay (GDD) is used to describe children from 0-5 years old with significant delays in 2 or more developmental areas. These delays may be transient but up to 2/3 of children with GDD will have ID. Overall 1-3% of the general population has ID which makes it very common. Most children with GDD/ID are identified because of delays in meeting milestones or general academic achievement. ID pat...
Source: PediatricEducation.org - May 3, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination
RARITAN, N.J., April 19, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that regulatory submissions based on the Phase 3 ACIS study, which evaluated the combination of ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC), will not be pursued. As presented at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cancers Symposium in February 2021, the ACIS study met its primary endpoint of radiographic progression-free survival (rPFS); ho...
Source: Johnson and Johnson - April 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

First lab-grown mini-thyroids use patients' own tissue
(International Society for Stem Cell Research) To investigate potential alternative treatment strategies for patients with hypothyroidism, researchers have now for the first time succeeded in generating thyroid mini-organs in the lab. In a new study published in Stem Cell Reports, Robert Coppes and colleagues from the University of Groningen, The Netherlands, used healthy thyroid tissue from patients undergoing surgical removal of the thyroid to grow mini-thyroid organs in a lab which resembled thyroid glands in their structure and protein content. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

New Trials on T3/T4 Combination for Hypothyroidism'Justified'New Trials on T3/T4 Combination for Hypothyroidism'Justified '
A joint conference concludes that new clinical trials are needed to consider evolving evidence in the ongoing debate over combination T3/T4 therapy for hypothyroidism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What Is the Best Treatment for Hypothyroidism?
Title: What Is the Best Treatment for Hypothyroidism?Category: Diseases and ConditionsCreated: 3/2/2021 12:00:00 AMLast Editorial Review: 3/2/2021 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - March 2, 2021 Category: Endocrinology Source Type: news

Janssen Announces Treatment with ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of the addition of ERLEADA® (apalutamide) to androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC), regardless of extent of disease, when compared to placebo plus ADT.[1] Results will be featured in an oral presentation at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cance...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo a...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

A Third Discontinuing Levothyroxine Have Normal Thyroid Levels A Third Discontinuing Levothyroxine Have Normal Thyroid Levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Hair loss treatment: Treating an under or overactive thyroid might boost hair growth
HAIR loss could be the result of severe and prolonged hypothyroidism or hyperthyroidism; this is confirmed by the British Thyroid Foundation. What are these conditions? (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2021 Category: Consumer Health News Source Type: news

What Causes Lethargy?
Discussion Lethargy is a common word used to describe a person who is drowsy, sluggish, listless and apathetic. Concentration may be difficult and they may have problems doing simple tasks. Many people actual mean fatigue or lassitude or being more tired when they use the word. In medical terms, lethargy is usually used to describe patients who have some type of excessive tiredness and usually have mental status changes with decreased alertness or arousal. Patients and health care providers both usually qualify the term and give more description to better communicate what is implied when using the term. This is true of man...
Source: PediatricEducation.org - January 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk
A large Swedish study shows those treated with LT3 in combination with LT4 for hypothyroidism have no greater breast cancer risk than individuals taking LT4 alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Consumer Health: What is hypothyroidism?
Are you over 60, feeling fatigued and slowly gaining weight? These may be subtle signs of hypothyroidism, or underactive thyroid. Your thyroid is a butterfly-shaped gland located at the base of your neck. With hypothyroidism, your thyroid gland doesn't produce enough of certain crucial hormones. As a result, hypothyroidism affects all aspects of your metabolism [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 4, 2021 Category: Databases & Libraries Source Type: news

What Effect Does Hypothyroidism Have On You?
Title: What Effect Does Hypothyroidism Have On You?Category: Diseases and ConditionsCreated: 12/15/2020 12:00:00 AMLast Editorial Review: 12/15/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - December 15, 2020 Category: Endocrinology Source Type: news

Hypothyroidism in Pregnant Woman May Raise Child's Risk of ADHD Hypothyroidism in Pregnant Woman May Raise Child's Risk of ADHD
Low levels of maternal thyroid hormone during the first three months of pregnancy may influence a fetus's brain development leaving the child at a greater risk of ADHD, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
Risk for ADHD increased in children of mothers with hypothyroidism diagnosed prior to, during pregnancy (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 21, 2020 Category: Psychiatry Tags: Endocrinology, Family Medicine, Gynecology, Internal Medicine, Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
WEDNESDAY, Oct. 21, 2020 -- Exposure to maternal hypothyroidism during the periconceptual period is associated with an increased risk for childhood attention-deficit hyperactivity disorder (ADHD) in offspring, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2020 Category: Pharmaceuticals Source Type: news

Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What Happens If Hypothyroidism Is Left Untreated
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 21, 2020 Category: General Medicine Source Type: news

Mayo Clinic Q and A: Hypothyroidism and dietary challenges
DEAR MAYO CLINIC: I was recently diagnosed with hypothyroidism and have been getting conflicting information on what I should eat and drink. I love yogurt and ice cream, for instance, but one source said a calcium-rich diet was fine, whereas another said I should limit dairy. I've also read that I should avoid soy and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 13, 2020 Category: Databases & Libraries Source Type: news

Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

What Causes Hypothyroidism?
Title: What Causes Hypothyroidism?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

What Happens If Hypothyroidism Is Left Untreated?
Title: What Happens If Hypothyroidism Is Left Untreated?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

Have I Been Doing This Exam Wrong All This Time? Have I Been Doing This Exam Wrong All This Time?
The Curbsiders share their favorite tips from a jam-packed podcast on hypothyroidism.The Curbsiders (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - August 24, 2020 Category: Universities & Medical Training Tags: Diabetes & Endocrinology Commentary Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Investor Update - July 31, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Media News - July 31, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news

Contribute to survey on treatment of hypothyroidism in Europe
You are invited to contribute to a series of national surveys of physicians on the management of hypothyroidism in Europe (THESIS; Treatment of Hypothyroidism in Europe by Specialists: an International Survey).The survey aims to gather information from physicians on a number of clinical practice topics relating to hypothyroidism. Whereas such data have been published from the US, there are few reflecting European practices. Twenty three European countries are already taking part.To help with the UK survey, which involves completing an online questionnaire, email Dr Carla Moran atcm682@me...
Source: Society for Endocrinology - July 16, 2020 Category: Endocrinology Source Type: news

Newborn Iodine Status Not Tied to Congenital Hypothyroidism
THURSDAY, July 9, 2020 -- Blood iodine concentrations in newborns do not vary for infants with or without congenital hypothyroidism (CH), although they are higher in cases versus controls in the neonatal intensive care unit (NICU), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news

Subclinical Hypothyroidism Appears Common in Women With Miscarriage Subclinical Hypothyroidism Appears Common in Women With Miscarriage
Among women with a history of miscarriage or subfertility, the prevalence of subclinical hypothyroidism is about 20% when using a TSH cutoff of 2.5 mIU/L.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2020 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news